Publications by authors named "Frank Baehner"

Claim this Profile
S
Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial.
Xavier Sáez-Llorens, Rodrigo deAntonio, Eduardo López-Medina, Pío López, Taisei Masuda, Frank Baehner

Hum Vaccin Immunother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varied treatment patterns among patients with palmoplantar pustulosis: A claims-based cohort study using data from 2 large US databases.
Jashin J Wu, Ran Gao, Rhonda L Bohn, Anouk Déruaz-Luyet, Stephani Gray, Frank Baehner

JAAD Int· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and tolerability of a bivalent virus-like particle norovirus vaccine candidate in children from 6 months up to 4 years of age: A phase 2 randomized, double-blind trial.
Pio López, Eduardo López-Medina, Xavier Sáez-Llorens, Rodrigo deAntonio, Taisei Masuda, Frank Baehner

Hum Vaccin Immunother· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding Study.
A David Burden, Robert Bissonnette, Alexander A Navarini, Masamoto Murakami, Akimichi Morita, Frank Baehner

Dermatol Ther (Heidelb)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding potential participation barriers to improve trial design and outcomes: clinical trial simulation in palmoplantar pustulosis as a case study.
Christian Boisvert-Huneault, David Trigos Herraez, Andreas Pinter, Satomi Kobayashi, Stacie Bell, Frank Baehner

BMJ Open· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a bivalent virus-like particle norovirus vaccine in children from 1 to 8 years of age: A phase 2 randomized, double-blind study.
Timo Vesikari, Xavier Saez-Llorens, Vezna Blazevic, Pio Lopez, Eduardo Lopez, Frank Baehner

Vaccine· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of the bivalent VLP norovirus vaccine candidate in older adults; impact of MPL adjuvant or a second dose.
John Treanor, Jim Sherwood, Jakob P Cramer, Nancy Le Cam Bouveret, Stella Lin, Frank Baehner

Vaccine· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence of Antibodies to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: 1-Year Follow-up With Memory Probe Vaccination.
Robert L Atmar, Frank Baehner, Jakob P Cramer, Eric Lloyd, James Sherwood

J Infect Dis· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Exploratory Study of the Salivary Immunoglobulin A Responses to 1 Dose of a Norovirus Virus-Like Particle Candidate Vaccine in Healthy Adults.
Robert L Atmar, Jakob P Cramer, Frank Baehner, Cong Han, Astrid Borkowski

J Infect Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of Different Formulations of Norovirus Vaccine Candidate in Healthy Adults: A Randomized, Controlled, Double-Blind Clinical Trial.
Geert Leroux-Roels, Jakob P Cramer, Paul M Mendelman, James Sherwood, Ralf Clemens, Frank Baehner

J Infect Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B-Cell Responses to Intramuscular Administration of a Bivalent Virus-Like Particle Human Norovirus Vaccine.
Sasirekha Ramani, Frederick H Neill, Jennifer Ferreira, John J Treanor, Sharon E Frey, Frank Baehner

Clin Vaccine Immunol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Pre-exposure History and Host Genetics on Antibody Avidity Following Norovirus Vaccination.
Lisa C Lindesmith, Michael L Mallory, Taylor A Jones, Charles Richardson, Robert R Goodwin, Frank Baehner

J Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Responses to 2 Virus-Like Particle Norovirus Vaccine Candidate Formulations in Healthy Adults: A Randomized Controlled Trial.
Robert L Atmar, Frank Baehner, Jakob P Cramer, Eric Song, Astrid Borkowski

J Infect Dis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological Correlates of Protection against a GII.4 Norovirus.
Robert L Atmar, David I Bernstein, G Marshall Lyon, John J Treanor, Mohamed S Al-Ibrahim, Frank Baehner

Clin Vaccine Immunol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAFETY OF A CRM197-CONJUGATED HAEMOPHILUS INFLUENZAE TYPE B VACCINE IN KOREAN CHILDREN.
Hyoyoung Song, Hans Bock, Alana Guadagno, Marco Costantini, Frank Baehner

Southeast Asian J Trop Med Public Health· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial.
Lisa C Lindesmith, Martin T Ferris, Clancy W Mullan, Jennifer Ferreira, Kari Debbink, Frank Baehner

PLoS Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oil-in-water emulsion adjuvant with influenza vaccine in young children.
Timo Vesikari, Markus Knuf, Peter Wutzler, Aino Karvonen, Dorothee Kieninger-Baum, Frank Baehner

N Engl J Med· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onset and progression of the Anderson-Fabry disease related cardiomyopathy.
Christoph Kampmann, Ales Linhart, Frank Baehner, Tomas Palecek, Christiane M Wiethoff

Int J Cardiol· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac manifestations of Anderson-Fabry disease in children and adolescents.
Christoph Kampmann, Christiane M Wiethoff, Catharina Whybra, Frank A Baehner, Eugen Mengel

Acta Paediatr· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IgA nephropathy in two adolescent sisters heterozygous for Fabry disease.
Catharina Whybra, Andreas Schwarting, Jörg Kriegsmann, Andreas Gal, Eugen Mengel, Frank Baehner

Pediatr Nephrol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac manifestations of Anderson-Fabry disease in heterozygous females.
Christoph Kampmann, Frank Baehner, Catharina Whybra, Claudia Martin, Christiane M Wiethoff

J Am Coll Cardiol· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac involvement in Anderson-Fabry disease.
Christoph Kampmann, Frank Baehner, Markus Ries, Michael Beck

J Am Soc Nephrol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis